About: Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors
Creator	Ciliberto, Gennaro Barba, Maddalena Botticelli, Andrea Krasniqi, Eriseld Pizzuti, Laura Vici, Patrizia
Source	Medline; PMC
abstract	covid:88110f844fc7decc2c4e0d96d41777c95fcdb0ff#abstract
has issue date	2020-06-03(xsd:dateTime)
bibo:doi	10.2217/imt-2020-0142
bibo:pmid	32489118
has license	cc-by
sha1sum (hex)	88110f844fc7decc2c4e0d96d41777c95fcdb0ff
schema:url	https://doi.org/10.2217/imt-2020-0142
resource representing a document's title	Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors
has PubMed Central identifier	PMC7273903
has PubMed identifier	32489118
schema:publication	Immunotherapy
resource representing a document's body	covid:88110f844fc7decc2c4e0d96d41777c95fcdb0ff#body_text
is schema:about of	named entity 'ADP-ribose' named entity 'landscape' named entity 'polymerase' named entity 'armamentarium' named entity 'therapeutic' named entity 'Risk' named entity 'CONSEQUENCE OF' named entity 'KNOWLEDGE' named entity 'MOLECULAR' named entity 'RIBOSE' named entity 'YEARS' named entity 'PROJECTIONS' named entity 'Poly' named entity 'ICIs' named entity 'tyrosine kinase inhibitors' named entity 'molecular' named entity 'immune checkpoint inhibitors' named entity 'Covid-19 pandemic' named entity 'epidemiologic' named entity 'infection' named entity 'SARS-CoV-2' named entity 'inflammatory' named entity 'infection' named entity 'hazard ratio' named entity 'pathogenesis' named entity 'PD-L1' named entity 'mechanism of action' named entity 'Italian' named entity 'ICI' named entity 'infection' named entity 'anti-PD-1' named entity 'Pfizer' named entity 'PD-L1' named entity 'Novartis' named entity 'tuberculosis' named entity 'breast cancer' named entity 'corticosteroids' named entity 'SARS-CoV-2' named entity 'self-tolerance' named entity 'anti-PD-1' named entity 'Italy' named entity 'Pfizer' named entity 'bacterial infections' named entity 'therapeutic approaches' named entity 'PD-L1' named entity 'SARS-Cov-2' named entity 'Covid-19 pandemic' named entity 'Covid' named entity 'Covid-19 pandemic' named entity 'lungs' named entity 'differential diagnosis' named entity 'hematological' named entity 'bone marrow' named entity 'neutropenia' named entity 'taxane' named entity 'hematologic' named entity 'CTLA4' named entity 'pathogenetic' named entity 'chemotherapy' named entity 'comorbidities' named entity 'breast cancer' named entity 'Italian' named entity 'ICIs' named entity 'adverse events' named entity 'Eisai' named entity 'infection' named entity 'respiratory disease' named entity 'ICIs' named entity 'lung cancer' named entity 'PD-L1' named entity 'Covid' named entity 'ICIs' named entity 'Roche' named entity 'infection' named entity 'kinase' named entity 'neutropenia'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software